Hussein Abbas

50PUBLICATIONS
264CO-AUTHORS
Gene and molecular therapyHaematological tumoursPredictive and prognostic markersRegenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Jul 06, 2026
Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II.

|Jun 11, 2026
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

|May 21, 2026
Chromosome 5q deletion drives evolution of aneuploidy in myeloid neoplasms with complex karyotype.

|Apr 14, 2026
Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial.

Jayastu Senapati, Hagop M Kantarjian, Edward Ayoub

|Mar 12, 2026
Immunophenotypic changes following menin inhibition in acute myeloid leukemia.

Sanam Loghavi, Aziz Farhat, Trevor J Jamison

|Feb 25, 2026
Epigenetic reactivation of the tumor suppressor ZBTB7A by KDM4 inhibition in human acute myeloid leukemia.

Alexander Arnuk, Cuijuan Han, Abimbola E Lawal

Pageof 9

Frequent Collaborators

24 joint publications

Naval G Daver

21 joint publications

Courtney DiNardo

17 joint publications

Nicholas J Short

17 joint publications

Marina Y Konopleva